Establishment and characterization of two human cell lines with amplified dihydrofolate reductase genes.
Two SV40-transformed human cell lines, GM637, derived from a normal human subject, and GM5849, derived from a patient with ataxia-telangiectasia (A-T), were grown in increasing concentrations of the cytotoxic agent methotrexate (MTX). The GM637 line was naturally more resistant to methotrexate than was GM5849 and, over a 5-month period, became resistant even to very high concentrations (up to 100 microM). The GM5849 line became resistant to 500 nM methotrexate during the same period. However, dot blot and Southern blot analyses showed that both cell lines had amplified their dihydrofolate reductase (dhfr) genes to about the same extent, approx. 50-fold. Using the GM5849 line with amplified dhfr, we attempted to determine if interruption of DNA synthesis by hydroxyurea would cause DNA to be replicated twice within a single cell cycle, as has been reported for Chinese hamster ovary cells. No evidence for such a phenomenon was obtained.
D002460:Cell Line; D002472:Cell Transformation, Viral; D003078:Colchicine / Q000494:pharmacology; D004261:DNA Replication / Q000187:drug effects; D004351:Drug Resistance / Q000235:genetics; D005347:Fibroblasts / Q000201:enzymology; D005784:Gene Amplification; D006801:Humans; D006918:Hydroxyurea / Q000494:pharmacology; D008727:Methotrexate / Q000494:pharmacology; D009693:Nucleic Acid Hybridization; D013539:Simian virus 40; D013762:Tetrahydrofolate Dehydrogenase / Q000235:genetics*
D013762:Tetrahydrofolate Dehydrogenase; D003078:Colchicine; D006918:Hydroxyurea; D008727:Methotrexate